Moreover, TRPM8 inhibition and silencing reduce proliferative capacity in pancreatic adenocarcinoma and prostate cancer cells (Yee et al., 2010; Valero et al., 2012). This evidence concerns the gene TRPM8 and prostate carcinoma.